Verastem (VSTM) Income towards Parent Company (2011 - 2026)

Verastem's (VSTM) quarterly Income towards Parent Company came in at -$44.5 million in Q1 2026, little changed year-on-year from -$44.5 million in Q1 2025, and down 1487.92% quarter-over-quarter from $3.2 million in Q4 2025.

Verastem (VSTM) Income towards Parent Company (2011 - 2026) Analysis & Trends

Verastem's Income towards Parent Company history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company changed 0.11% year-over-year to -$44.5 million in Q1 2026; TTM through Mar 2026 was -$139.5 million, a 5.54% decrease from a year earlier, with the FY2025 full-year figure at -$165.5 million, down 26.66% from the prior year.
  • Income towards Parent Company fell to -$44.5 million in Q1 2026 per VSTM's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $3.2 million in Q4 2025 and bottomed at -$54.0 million in Q2 2025.
  • The 5-year median for Income towards Parent Company is -$22.0 million (2022), against an average of -$27.4 million.
  • Biggest YoY gain for Income towards Parent Company was 110.02% in 2025; the steepest drop was 192.7% in 2025.
  • Year by year, Income towards Parent Company stood at -$16.8 million in 2022, then plunged by 76.25% to -$29.6 million in 2023, then retreated by 7.96% to -$32.0 million in 2024, then soared by 110.02% to $3.2 million in 2025, then tumbled by 1487.92% to -$44.5 million in 2026.
  • Per Business Quant, the three latest VSTM Income towards Parent Company figures stand at -$44.5 million (Q1 2026), $3.2 million (Q4 2025), and -$44.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Verastem 607.94 Mn 410.11 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.46 Mn
Dec 31, 2025 3.20 Mn
Sep 30, 2025 -44.28 Mn
Jun 30, 2025 -53.95 Mn
Mar 31, 2025 -44.41 Mn
Dec 31, 2024 -31.97 Mn
Sep 30, 2024 -37.35 Mn
Jun 30, 2024 -18.43 Mn
Mar 31, 2024 -31.23 Mn
Dec 31, 2023 -29.61 Mn
Sep 30, 2023 -20.19 Mn
Jun 30, 2023 -20.29 Mn
Mar 31, 2023 -19.14 Mn
Dec 31, 2022 -16.80 Mn
Sep 30, 2022 -18.17 Mn
Jun 30, 2022 -21.96 Mn
Mar 31, 2022 -17.19 Mn
Dec 31, 2021 -16.48 Mn
Sep 30, 2021 -24.95 Mn
Jun 30, 2021 -34.78 Mn